This announcement is a separate document:
百奥泰 自愿披露关于度普利尤单抗注射液（BAT2406）获得药物临床试验批准通知书的公告
Biotech voluntarily disclosed the notice of approval for dupriumab injection (BAT2406) for drug clinical trials
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated